Osteolytic and mixed cancer metastasis modulates collagen and mineral parameters within rat vertebral bone matrix
Authors:
Open Access
- 30 March 2016
- journal article
- research article
- Published by Wiley in Journal of Orthopaedic Research
- Vol. 34 (12) , 2126-2136
Abstract
Metastatic involvement in vertebral bone diminishes the mechanical integrity of the spine; however minimal data exist on the potential impact of metastases on the intrinsic material characteristics of the bone matrix. Thirty‐four (34) female athymic rats were inoculated with HeLa (N = 17) or Ace‐1 (N = 17) cancer cells lines producing osteolytic or mixed (osteolytic and osteoblastic) metastases, respectively. A maximum of 21 days was allowed between inoculation and rat sacrifice for vertebrae extraction. High performance liquid chromatography (HPLC) was utilized to determine modifications in collagen‐I parameters such as proline hydroxylation and the formation of specific enzymatic and non‐enzymatic (pentosidine) cross‐links. Raman spectroscopy was used to determine relative changes in mineral crystallinity, mineral carbonation, mineral/collagen matrix ratio, collagen quality ratio, and proline hydroxylation. HPLC results showed significant increase in the formation of pentosidine and decrease in the formation of the enzymatic cross‐link deoxy‐pryridinoline within osteolytic bone compared to mixed bone. Raman results showed decreased crystallinity, increased carbonation, and collagen quality (aka 1660/1690 sub‐band) ratio with osteolytic bone compared to mixed bone and healthy controls along with an observed increase in proline hydroxylation with metastatic involvement. The mineral/matrix ratio decreased in both osteolytic and mixed bone compared to healthy controls. Quantifying modifications within the intrinsic characteristics of bone tissue will provide a foundation to assess the impact of current therapies on the material behavior of bone tissue in the metastatic spine and highlight targets for the development of new therapeutics and approaches for treatment. © 2016 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 34:2126–2136, 2016.Keywords
Funding Information
- Canadian Institutes of Health Research (68911, 125886)
This publication has 47 references indexed in Scilit:
- The Ratio 1660/1690 cm−1 Measured by Infrared Microspectroscopy Is Not Specific of Enzymatic Collagen Cross-Links in Bone TissuePLOS ONE, 2011
- Evaluating the effects of mixed osteolytic/osteoblastic metastasis on vertebral bone quality in a new rat modelJournal of Orthopaedic Research, 2011
- Hydroxyapatite nanoparticle-containing scaffolds for the study of breast cancer bone metastasisBiomaterials, 2011
- Beyond bisphosphonates: photodynamic therapy structurally augments metastatically involved vertebrae and destroys tumor tissueBreast Cancer Research and Treatment, 2010
- Type 1 Diabetes in Young Rats Leads to Progressive Trabecular Bone Loss, Cessation of Cortical Bone Growth, and Diminished Whole Bone Strength and Fatigue LifeJournal of Bone and Mineral Research, 2009
- Stat3 Promotes Metastatic Progression of Prostate CancerThe American Journal of Pathology, 2008
- Trabecular microfracture and the influence of pyridinium and non-enzymatic glycation-mediated collagen cross-linksBone, 2005
- Mechanical properties, density and quantitative CT scan data of trabecular bone with and without metastasesJournal of Biomechanics, 2004
- Free radical-mediated oxidation of free amino acids and amino acid residues in proteinsAmino Acids, 2003
- Metastatic Bone TumorsClinical Orthopaedics and Related Research, 1993